4.5 Review

Mimics of Inflammatory Bowel Disease

期刊

INFLAMMATORY BOWEL DISEASES
卷 24, 期 11, 页码 2315-2321

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/ibd/izy168

关键词

inflammatory bowel disease; mimics

资金

  1. Celgene
  2. Janssen Orthobiotech
  3. Salix Pharmaceuticals/Valeant
  4. Santarus/Receptos/Celgene
  5. Shire Pharmaceuticals
  6. UCB
  7. Pfizer Pharmaceuticals
  8. Takeda

向作者/读者索取更多资源

Inflammatory bowel disease (IBD) may present with nonspecific symptoms and diagnostic findings. Therefore, many diseases may mimic the clinical symptoms, endoscopic findings, and histologic features of IBD. In this paper, we will review mimics of IBD, dividing the diseases that can imitate IBD into noninfectious and infectious causes. For each disease state, we will discuss the clinical symptoms and endoscopic and histologic features. Finally, we will discuss how to distinguish these distinct disorders from IBD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据